​We’re delighted to have been selected as the headline sponsor of the fifth edition of Cure3, an event hosted by Cure Parkinson’s to raise money to fund research into finding a cure for Parkinson’s Disease.

Helping to fund the much-needed research into finding a cure for Parkinson’s would be close to our hearts here at Quant even if it wasn’t the fastest growing degenerative neurological condition in the world, affecting over 8.5 million people worldwide.

Many of us know someone impacted by a condition that we believe will one day be cured by determination, science and technology. That’s why we’re so proud to support Cure3’s important work by being the headline sponsor for the fifth edition of their sale that’s taking place on Monday 3 February at Bonhams Gallery in London.

As a team, we share many of the values of Cure3. Most notably perhaps, a determination to apply innovation and ambition to overcoming complex challenges. As the funds raised by Cure3 enable some of the most promising clinical research and trials today, I can’t help but imagine a future where Quant’s work – on programmable, digital money and conditional payments – might also have a role to play in driving efficiency within clinical trials.

It’s easy to envision a world where this transformative technology could be applied to healthcare by making the sector more efficient, lowering costs, and – who knows – perhaps even automatically funneling charitable payments to the areas where they will do the most good. We’ll certainly keep working on it.

In the meantime, there is one example of technology being applied in this space that you don’t need to imagine. For the second year, Cure3 has included in its sale of traditional art some purely digital pieces in the form of non-fungible tokens, or NFTs. These innovative works illustrate a valuable application of smart money: every time their ownership changes hands in the future, a further contribution is automatically made to Cure3 and its efforts to cure Parkinson’s. It’s hard to imagine a more worthwhile use of digital money and I commend the Cure3 team for combining traditional and digital art forms like this.

​Like them, we’re passionate about building a world where the established and the innovative co-exist seamlessly. Perhaps finance and art aren’t as different after all.

Back to News
Share:

“I can’t help but imagine a future where Quant’s work – on programmable, digital money and conditional payments – might also have a role to play in driving new efficiencies within healthcare.”

Gilbert Verdian
Founder and CEO
Subscribe and be the first to know